Our formulation has been extensively tested and researched independently by the UTS Biomedical Sciences Faculty over a 5-year plus period where by results have confirmed the product’s efficacy and potential benefits for major conditions that are increasingly affecting the overall health of society today.

Plasmaide has entered into a clinical trial program with the University of Technology, Sydney over a two year period.

Below is a list of clinical studies that demonstrate the effectiveness of Pinus Pinaster - the active ingredient in Plasmaide.

 

References

 

1.        McGrath KCY, Li X-H, McRobb LS, et al. (2015) Inhibitory Effect of a French Maritime Pine Bark Extract-Based Nutritional Supplement on TNF- α -Induced Inflammation and Oxidative Stress in Human Coronary Artery Endothelial Cells. Evidence-Based Complement Altern Med 2015:1–7. doi: 10.1155/2015/260530

2.        Saliou C, Rimbach G, Moini H, et al.(2001) Solar ultraviolet-induced erythema in human skin and nuclear factor-kappa-B-dependent gene expression in keratinocytes are modulated by a French maritime pine bark extract. Free Radic Biol Med 30:154–160. doi: 10.1016/S0891-5849(00)00445-7

3.        Blazsó G, Gábor M, Rohdewald P (1997) Antiinflammatory activities of procyanidin-containing extracts from Pinus pinaster Ait. after oral and cutaneous application. Pharmazie 52:380–2.